ARCA biopharma P/E Ratio 2011-2026 | ABIO

Annual P/E Ratio ARCA biopharma

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006	2005	2004	2003
-	-5.78	-4.27	-3.02	-1.36	-2.61	-1.27	-0.768	-1.02	-1.4	-2.08	-1.5	-2.49	-2.1	-1.85	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
-0.768	-5.78	-2.25

P/E Ratio of other stocks in the Biotechnology industry

Issuer	P/E Ratio	Price	% 24h	Market Cap	Country
FSD Pharma HUGE	-2.15	-	5743.5 %	$ 69.7 M	Canada
MorphoSys AG MOR	-0.612	-	2.43 %	$ 254 M	Germany
Happiness Biotech Group Limited HAPP	-0.183	-	1.35 %	$ 17.8 M	China
Amphastar Pharmaceuticals AMPH	12.7	$ 16.89	-2.37 %	$ 789 M	USA
AgeX Therapeutics AGE	5.53	-	-10.17 %	$ 12.2 K	USA
Compugen Ltd. CGEN	5.55	$ 2.85	-5.94 %	$ 266 M	Israel
I-Mab IMAB	-0.236	-	-	$ 866 M	China
Coherus BioSciences CHRS	1.35	$ 1.58	-3.37 %	$ 185 M	USA
Alexion Pharmaceuticals, Inc. ALXN	55.7	-	-	$ 40.3 B	USA
Biophytis SA BPTS	-17.6	-	-13.47 %	$ 169 M	France
Genfit SA GNFT	2.49 K	-	2.54 %	$ 160 B	France
AstraZeneca PLC AZN	16.3	-	-	$ 96.9 B	Britain
EyeGate Pharmaceuticals, Inc. EYEG	-3.57	-	-1.52 %	$ 24.7 M	USA
Arcturus Therapeutics Holdings ARCT	-3.3	$ 7.46	-4.73 %	$ 204 M	Israel
Athira Pharma ATHA	-0.0167	-	-	$ 269 M	USA
BiondVax Pharmaceuticals Ltd. BVXV	-18.5	-	0.74 %	$ 768 M	Israel
Galera Therapeutics GRTX	-0.403	-	-32.59 %	$ 7.61 M	USA
Eton Pharmaceuticals ETON	-121	$ 29.73	-0.77 %	$ 800 M	USA
Exelixis EXEL	15	$ 50.09	-1.98 %	$ 13.6 B	USA
Midatech Pharma plc MTP	-251	-	-18.52 %	$ 27.3 M	Britain
Fortress Biotech FBIO	2.1	$ 2.47	7.39 %	$ 68.9 M	USA
Forte Biosciences FBRX	-4.83	$ 22.53	-5.97 %	$ 292 M	USA
Fennec Pharmaceuticals FENC	-0.0173	$ 9.51	2.92 %	$ 272 M	USA
AbCellera Biologics ABCL	-6.57	$ 4.03	-8.52 %	$ 1.2 B	Canada
Autolus Therapeutics plc AUTL	-1.12	$ 1.57	-1.26 %	$ 418 M	Britain
Институт стволовых клеток человека ISKJ	38.8	-	-	-	Russia
BioNTech SE BNTX	-19.4	$ 88.94	-3.32 %	$ 21.5 B	Germany
Checkmate Pharmaceuticals CMPI	-0.859	-	-	$ 231 M	USA
Galectin Therapeutics GALT	-5.78	$ 2.22	-5.74 %	$ 142 M	USA
Gilead Sciences GILD	21.6	$ 129.56	-1.9 %	$ 161 B	USA
Genmab A/S GMAB	0.243	$ 26.79	-0.41 %	$ 1.73 B	Danmark
Advaxis ADXS	-0.0388	-	-9.65 %	$ 45.9 M	USA
Can-Fite BioPharma Ltd. CANF	-0.489	$ 3.36	-5.62 %	$ 5.53 M	Israel
Aeterna Zentaris AEZS	-0.964	-	5.93 %	$ 314 M	Canada
Aeglea BioTherapeutics AGLE	-3.48	-	-	$ 1.01 B	USA
CureVac N.V. CVAC	-8.58	-	-	$ 867 M	Germany
Applied Genetic Technologies Corporation AGTC	-1.71	-	-	$ 26.5 M	USA
Grifols, S.A. GRFS	21.2	$ 7.67	-1.6 %	$ 5.21 B	Spain
AIkido Pharma AIKI	-1.33	-	1.93 %	$ 17.4 M	USA
Enlivex Therapeutics Ltd. ENLV	0.0355	$ 0.72	-1.76 %	$ 32.9 M	Israel
Akero Therapeutics AKRO	-12.9	-	-	$ 3.67 B	USA
Esperion Therapeutics ESPR	-24.7	$ 3.13	0.32 %	$ 651 M	USA
Aptose Biosciences APTO	-0.0913	-	-45.71 %	$ 1.2 M	Canada
Aptinyx APTX	-0.146	-	-39.0 %	$ 4.57 M	USA
Akouos AKUS	-1.98	-	0.23 %	$ 488 M	USA
Albireo Pharma ALBO	-15.8	-	-0.23 %	$ 916 M	USA
AlloVir ALVR	-0.189	-	4.14 %	$ 49.1 M	USA
Allakos ALLK	-0.612	-	-	$ 28.6 M	USA
Arcutis Biotherapeutics ARQT	-213	$ 21.66	0.42 %	$ 2.76 B	USA
Allena Pharmaceuticals ALNA	-2.17	-	3.16 %	$ 1.9 M	USA